Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
AIMS: In this study, we sought to determine the role of ecto-nucleotidases and adenosine receptors in calcific aortic valve disease (CAVD). The expression of ecto-nucleotidases, which modify the levels of extracellular nucleotides/nucleosides, may control the mineralization of valve interstitial cells (VICs). We hypothesized that expression of ectonucleotide pyrophosphatase/phosphodiesterase 1 (NPP1), which generates AMP, and 5'-nucleotidase (CD73), an enzyme using AMP as a substrate to produce adenosine, may co-regulate the mineralization of the aortic valve. METHODS AND RESULTS: We have investigated the expression of NPP1 and 5'-nucleotidase in CAVD tissues and determined the role of these ecto-nucleotidases on the mineralization of isolated VICs. In CAVD tissues (stenotic and sclerotic), we documented that NPP1 and 5'-nucleotidase were overexpressed by VICs. In isolated VICs, we found that mineralization induced by adenosine triphosphate was decreased by silencing NPP1 and 5'-nucleotidase, suggesting a role for adenosine. Adenosine and specific A2a adenosine receptor (A2aR) agonist increased the mineralization of VICs. Silencing of A2aR in human VICs and the use of A2aR(-/-) mouse VICs confirmed that A2aR promotes the mineralization of cells. Also, A2aR-mediated mineralization was negated by the transfection of a mutant dominant-negative Gαs vector. Through several lines of evidence, we next documented that adenosine stimulated the mineralization of VICs through a cAMP/protein kinase A (PKA)/cAMP response element-binding protein (CREB) pathway, and found that CREB positively regulated the expression of NPP1 in a positive feedback loop by physically interacting with the promoter. CONCLUSION: Expression of NPP1 and 5'-nucleotidase by VICs promotes the mineralization of the aortic valve through A2aR and a cAMP/PKA/CREB pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“several ectonucleotidases such as ALP, ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E-NPP 1) and 5′-nucleotidase (5′-NT, also called CD73) are overexpressed in human stenotic aortic valves”
From Calcific aortic stenosis (2016) · cites this paper as [111]
In the citing paper
“the over activity of E-NPP 1 and 5′-NT in human stenotic aortic valves depletes extracellular ATP and produces adenosine111.”
From Calcific aortic stenosis (2016) · cites this paper as [111]
Citations
Cites
Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL
Heinemeyer, T. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.362 · Cited by 1,451
Yegutkin, G. G. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.024 · Cited by 1,154 · cited 1×
“Also, it is possible that, by producing AMP, NPP1 modulates the signalling through adenosine receptors.(10) To this effect, 5′-nucleotidase (CD73) is using AMP as a substrate to produce adenosine, which could exert a control over the mineralization of the aortic valve.”
Bours, M. J. L., Swennen, E. L. R., Di Virgilio, F., Cronstein, B. N., & Dagnelie, P. C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.013 · Cited by 1,030 · cited 2×
“Therefore, in conditions where NPP1 and 5′-nucleotidase are co-expressed and up-regulated, it is likely that adenosine will be produced and therefore will modulate the function of adenosine receptors.(22) We found that HVICs expressed a high level of NPP1 and 5′-nucleotidase.”
Rajamannan, N. M., Evans, F. J., Aikawa, E., Grande-Allen, K. J., Demer, L. L., Heistad, D. D., Simmons, C. A., Masters, K. S., Mathieu, P., O'Brien, K. D., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.006767 · Cited by 842
Self-citationThe Emerging Role of Valve Interstitial Cell Phenotypes in Regulating Heart Valve Pathobiology
Liu, A. C., Joag, V. R., & Gotlieb, A. I. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070251 · Cited by 632
NT5E Mutations and Arterial Calcifications
St. Hilaire, C., Ziegler, S. G., Markello, T. C., Brusco, A., Groden, C., Gill, F., Carlson-Donohoe, H., Lederman, R. J., Chen, M. Y., Yang, D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0912923 · Cited by 455
Okawa, A., Nakamura, I., Goto, S., Moriya, H., Nakamura, Y., & Ikegawa, S. (1998) · Nature Genetics · doi:10.1038/956 · Cited by 422 · cited 1×
“PPi is a strong inhibitor of mineralization and NPP1 knockout mice develop ectopic mineralization of tendons.(5) On the other hand, overexpression of NPP1 in VICs and chrondrocytes”
Messika-Zeitoun, D., Aubry, M.-C., Detaint, D., Bielak, L. F., Peyser, P. A., Sheedy, P. F., Turner, S. T., Breen, J. F., Scott, C., Tajik, A. J., et al. (2004) · Circulation · doi:10.1161/01.cir.0000135469.82545.d0 · Cited by 386
Caira, F. C., Stock, S. R., Gleason, T. G., McGee, E. C., Huang, J., Bonow, R. O., Spelsberg, T. C., McCarthy, P. M., Rahimtoola, S. H., & Rajamannan, N. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.02.040 · Cited by 371
Goding, J. W., Grobben, B., & Slegers, H. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(03)00058-9 · Cited by 364 · cited 6×
“Accordingly, a recent report has also documented that porcine VICs express 5′-nucleotidase.23 Transforming growth factor-b1, a growth factor suspected to play a role in CAVD, is also a positive regulator of NPP1.”
InfluentialCalcification by Valve Interstitial Cells Is Regulated by the Stiffness of the Extracellular Matrix
Yip, C. Y. Y., Chen, J.-H., Zhao, R., & Simmons, C. A. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.182394 · Cited by 329 · cited 1×
“In this study, VICs were grown on a rigid polystyrene support, which has been shown to mimic the biomechanical properties found in sclerotic valves.(38) Thus, the present findings suggest that modulation of ecto-nucleotidases/purinergic receptor may affect the biology of VICs early during the course of CAVD.”
Mechanisms of ATP release and signalling in the blood vessel wall
Lohman, A. W., Billaud, M., & Isakson, B. E. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs187 · Cited by 302 · cited 1×
“By using different mechanisms, such as exocytosis and channel-mediated transport, ATP is released by vascular and valvular cells.(18) In isolated VICs, Osman et al.”
Chen, J.-H., Yip, C. Y. Y., Sone, E. D., & Simmons, C. A. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080750 · Cited by 208 · cited 1×
“VICs represent a heterogeneous population including a subpopulation with a strong osteogenic potential.(35,36) It is believed that VICs undergo an osteogenic programme during CAVD, whereby the mineralization of valvular tissue is promoted.”
Adenosine receptors as drug targets
Fredholm, B. B. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.004 · Cited by 207
Chen, J.-H., Chen, W. L. K., Sider, K. L., Yip, C. Y. Y., & Simmons, C. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.220061 · Cited by 189
cAMP Stimulates Osteoblast-like Differentiation of Calcifying Vascular Cells
Tintut, Y., Parhami, F., Boström, K., Jackson, S. M., & Demer, L. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7547 · Cited by 180 · cited 1×
“The mineralization of vascular smooth cells has been shown to be dependent on the cAMP/PKA pathway.(34) Recently, Mahmut et al.”
Activity loss and the onset of depressive symptoms: Do some activities matter more than others?
Katz, P. P., & Yelin, E. H. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200105)44:5<1194::aid-anr203>3.0.co;2-6 · Cited by 175
Johnson, K., Hashimoto, S., Lotz, M., Pritzker, K., Goding, J., & Terkeltaub, R. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200105)44:5<1071::aid-anr187>3.0.co;2-3 · Cited by 159
Elevated Expression of Lipoprotein-Associated Phospholipase A2 in Calcific Aortic Valve Disease
Mahmut, A., Boulanger, M., Husseini, D. E., Fournier, D., Bouchareb, R., Després, J., Pîbarot, P., Bossé, Y., & Mathieu, P. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.105 · Cited by 153 · cited 9×
“We hypothesized that ATP, which could be hydrolyzed Downloaded from https://academic.oup.com/cardiovascres/article-abstract/106/1/109/286613 by guest on 29 July 2018 Figure 1 Levels of NPP1 and 5′-nucleotidase in CAVD.”
InfluentialSelf-citationEl Husseini, D., Boulanger, M.-C., Mahmut, A., Bouchareb, R., Laflamme, M.-H., Fournier, D., Pibarot, P., Bossé, Y., & Mathieu, P. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.02.014 · Cited by 150
Self-citationYu, L., Huang, Z., Mariani, J., Wang, Y., Moskowitz, M. A., & Chen, J. (2004) · Nature Medicine · doi:10.1038/nm1103 · Cited by 139 · cited 1×
“Also, A2aR deficiency has been shown to protect against ischaemic brain injury.(33) In the present work, through several lines of evidence, we showed that A2aR promotes the mineralization of the aortic valve through a cAMP/PKA pathway.”
CD73‐generated adenosine promotes osteoblast differentiation
Takedachi, M., Oohara, H., Smith, B. J., Iyama, M., Kobashi, M., Maeda, K., Long, C. L., Humphrey, M. B., Stoecker, B. J., Toyosawa, S., et al. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.23001 · Cited by 122 · cited 1×
“Moreover, in bone cells, 5′-nucleotidase-derived adenosine promotes the differentiation of osteoblast.(28) Accordingly, in the present work, we found that VICs expressed a high level of 5′-nucleotidase; furthermore, we documented that adenosine promoted the mineralization of cell cultures and the expression of osteobl…”
(2005) · PubMed · Cited by 99
Self-citationCalcification of the aortic valve: Its progression and grading
Warren, B. A., & Yong, J. L. C. (1997) · Pathology · doi:10.1080/00313029700169315 · Cited by 98
ATP acts as a survival signal and prevents the mineralization of aortic valve
Côté, N., El Husseini, D., Pépin, A., Guauque-Olarte, S., Ducharme, V., Bouchard-Cannon, P., Audet, A., Fournier, D., Gaudreault, N., Derbali, H., et al. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.02.003 · Cited by 95 · cited 7×
“Cote et al.(3) previously showed that single-nucleotide polymorphisms for the gene encoding ectonucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) were associated with CAVD and a higher level of NPP1 in mineralized aortic valves.”
InfluentialSelf-citationSpychała, J., & Kitajewski, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.11.001 · Cited by 86 · cited 1×
“The Wnt signalling pathway, which is activated during CAVD,(25,26) activates the expression of 5′-nucleotidase.(27) Moreover, in bone cells, 5′-nucleotidase-derived adenosine promotes the differentiation of osteoblast.”
Johnson, K., Pritzker, K. P. H., Goding, J. W., & Terkeltaub, R. A. (2001) · PubMed · Cited by 85
Chiang, D. J., Roychowdhury, S., Bush, K., McMullen, M. R., Pisano, S., Niese, K., Olman, M. A., Pritchard, M. T., & Nagy, L. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069114 · Cited by 82 · cited 1×
“In the liver, the A2aR antagonists have been shown to prevent fibrosis.(31) On the other hand, the A2aR has been shown to mediate a pro-inflammatory effect in different models.”
Recruitment of bone marrow-derived valve interstitial cells is a normal homeostatic process
Hajdu, Z., Romeo, S. J., Fleming, P. A., Markwald, R. R., Visconti, R. P., & Drake, C. J. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.08.006 · Cited by 76
Wang, H., Zhang, W., Zhu, C., Bucher, C., Blazar, B. R., Zhang, C., Chen, J.-F., Linden, J., Wu, C., & Huo, Y. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.188839 · Cited by 71
Towler, D. A. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000158943.79580.9d · Cited by 65 · cited 1×
“NPP1 generates PPi, which can be metabolized by alkaline phosphatase (ALP) into phosphate (Pi), which is a strong promoter of mineralization.(8,9)”
Osman, L., Chester, A. H., Amrani, M., Yacoub FRS, M. H., & Smolenski MD, R. T. (2006) · Circulation · doi:10.1161/circulationaha.105.001214 · Cited by 63 · cited 2×
“In isolated VICs, Osman et al.(19) showed that ATP promoted the expression of ALP.”
Poggio, P., Sainger, R., Branchetti, E., Grau, J. B., Lai, E. K., Gorman, R. C., Sacks, M. S., Parolari, A., Bavaria, J. E., & Ferrari, G. M. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt055 · Cited by 53 · cited 1×
“It is believed that VICs undergo an osteogenic programme during CAVD, whereby the mineralization of valvular tissue is promoted.(37) In this study, VICs were grown on a rigid polystyrene support, which has been shown to mimic the biomechanical properties found in sclerotic valves.”
Rattazzi, M., Iop, L., Faggin, E., Bertacco, E., Zoppellaro, G., Baesso, I., Puato, M., Torregrossa, G., Fadini, G. P., Agostini, C., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.174342 · Cited by 47 · cited 1×
“VICs represent a heterogeneous population including a subpopulation with a strong osteogenic potential.(35,36) It is believed that VICs undergo an osteogenic programme during CAVD, whereby the mineralization of valvular tissue is promoted.”
Npp1 promotes atherosclerosis in ApoE knockout mice
Nitschke, Y., Weissen-Plenz, G., Terkeltaub, R., & Rutsch, F. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01327.x · Cited by 46 · cited 1×
“mice have a similar level of vascular mineralization when compared with ApoE mice.(21) These data suggest that NPP1 promotes atherosclerosis, and that a certain amount of NPP1 is required to prevent excessive mineralization.”
Côté, N., Husseini, D. E., Pépin, A., Bouvet, C., Gilbert, L.-A., Audet, A., Fournier, D., Pîbarot, P., Moreau, P. R., & Mathieu, P. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.05.016 · Cited by 43 · cited 1×
“We previously showed in a rat model that mineralization of the aortic valve is prevented by the use of ecto-nucleotidases inhibitor.(39) However, for the time being there is no potent and selective inhibitor of ecto-nucleotidases.”
Self-citationOkawa, A., Ikegawa, S., Nakamura, I., Goto, S., Moriya, H., & Nakamura, Y. (1998) · Mammalian Genome · doi:10.1007/s003359900707 · Cited by 39 · cited 1×
“consequence of the absence or the near-absence of PPi, a crucial and important inhibitor of mineralization.(20) A recent report showed that APOE NPP1 and APOE NPP1+/2 mice develop smaller atherosclerotic lesions, whereas the heterozygous ApoE NPP1+/2”
Regulation of Atherosclerosis and Associated Risk Factors by Adenosine and Adenosine Receptors
Koupenova, M., Johnston‐Cox, H., & Ravid, K. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0263-y · Cited by 38 · cited 1×
“In atherosclerosis, adenosine receptors have been shown to play an important role.(12) However, the function of adenosine receptors in CAVD is still unknown.”
Kaniewska, E., Sielicka, A., Sarathchandra, P., Pelikant‐Małecka, I., Olkowicz, M., Slominska, E. M., Chester, A. H., Yacoub, M. H., & Smolenski, R. T. (2014) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2014.885985 · Cited by 17
Zankov, D. P., Omatsu‐Kanbe, M., Toyoda, F., Ding, W., Matsuura, H., Isono, T., & Horie, M. (2006) · Circulation · doi:10.1161/circulationaha.106.640854 · Cited by 17
Pharmacology of ectonucleotidases: Relevance for the treatment of cardiovascular disorders
Mathieu, P. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.09.003 · Cited by 16 · cited 2×
“However, for the time being there is no potent and selective inhibitor of ecto-nucleotidases.(4) The development of such inhibitor would represent a breakthrough in order to A.”
Self-citation
Cited by
Lindman, B. R., Clavel, M.-A., Mathieu, P., Iung, B., Lancellotti, P., Otto, C. M., & Pibarot, P. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.6 · Cited by 982
Self-citationCalcific aortic valve disease: mechanisms, prevention and treatment
Moncla, L.-H. M., Briend, M., Bossé, Y., & Mathieu, P. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00845-7 · Cited by 306
Self-citationHadji, F., Boulanger, M.-C., Guay, S.-P., Gaudreault, N., Amellah, S., Mkannez, G., Bouchareb, R., Marchand, J. T., Nsaibia, M. J., Guauque-Olarte, S., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.023116 · Cited by 223
Self-citationMedical Treatment of Aortic Stenosis
Marquis-Gravel, G., Redfors, B., Leon, M. B., & Généreux, P. (2016) · Circulation · doi:10.1161/circulationaha.116.023997 · Cited by 162
Role of oxidative stress in calcific aortic valve disease and its therapeutic implications
Greenberg, H. Z. E., Zhao, G., Shah, A. M., & Zhang, M. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab142 · Cited by 123
Metadata
- Authors
- Mahmut, A., Boulanger, M.-C., Bouchareb, R., Hadji, F., & Mathieu, P.
- Affiliations
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Corresponding author
- Mathieu, Patrick
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-02-02
- Volume
- 106
- Issue
- 1
- Pages
- 109-120
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W1995437010
- Cited by
- 48
- References
- 41
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 5 · 2020: 2 · 2019: 9 · 2018: 4 · 2017: 3 · 2016: 8 · 2015: 1
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval (MOP114893, MOP245048)
- Canadian Institutes of Health Research (MOP114893, MOP-245048)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
- Keywords
- calcific aortic valve disease, ectonucleotidases, adenosine, adenosine A2A receptor, NPP1, CD73, 5'-nucleotidase, valvular interstitial cells, calcification, cAMP/PKA/CREB pathway, extracellular nucleotides
- MeSH terms
- Bicuspid Aortic Valve Disease, Adenosine, Cyclic AMP, Adenosine Triphosphatases, Aged, Animals, Aortic Valve, Aortic Valve Stenosis, Calcinosis, Disease Models, Animal, Female, Heart Defects, Congenital, Heart Valve Diseases, Humans, Male, Middle Aged, Phosphoric Diester Hydrolases, Pyrophosphatases, Signal Transduction, 5'-Nucleotidase, Cyclic AMP Response Element-Binding Protein, Cyclic AMP-Dependent Protein Kinases, Mice, Knockout, Receptor, Adenosine A2A, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.